avoidant personality disorder
Summary
Avoidant personality disorder (AvPD) is a Cluster C ("anxious/fearful") personality disorder marked by lifelong social inhibition, feelings of inadequacy, and hypersensitivity to negative evaluation. Patients desperately WANT relationships but avoid them due to fear of rejection, criticism, or embarrassment. Treatment is psychotherapy (CBT, schema therapy, social skills/group training); medications (SSRIs) are for comorbid anxiety/depression.
Detail
**Definition (DSM-5-TR):** A pervasive pattern of social inhibition, feelings of inadequacy, and hypersensitivity to negative evaluation, beginning by early adulthood, with ≥4 of 7 criteria: 1. Avoids occupational activities involving significant interpersonal contact (fear of criticism, disapproval, rejection) 2. Unwilling to get involved with people unless certain of being liked 3. Restrained in intimate relationships due to fear of shame or ridicule 4. Preoccupied with being criticized or rejected in social situations 5. Inhibited in new interpersonal situations due to feelings of inadequacy 6. Views self as socially inept, personally unappealing, or inferior 7. Unusually reluctant to take personal risks or engage in new activities because they may prove embarrassing
**Pathophysiology/Etiology:** Multifactorial: temperamental behavioral inhibition/shyness in childhood (heritable), early parental rejection or criticism, peer rejection/bullying, and emotional neglect. Cognitive model: core beliefs of being defective or unlovable, with attentional bias toward signs of rejection and reinforcement of avoidance through reduced anxiety (negative reinforcement). Psychodynamic: low self-esteem, shame. Prevalence is about 2–3%, with roughly equal sex distribution.
**Clinical significance/Key associations:** - Cluster C (anxious/fearful): avoidant, dependent, obsessive-compulsive PD. - Strong comorbidity and overlap with social anxiety disorder (generalized type); AvPD is often considered a more severe, pervasive end of the spectrum. Also associated with depression, other anxiety disorders, and substance use. - Defense mechanism: fantasy and avoidance (also withdrawal/inhibition). - Personality traits are ego-syntonic in some PDs, but avoidant patients are typically ego-dystonic: they feel distressed by their isolation and crave closeness.
**Key differentiators (high-yield for boards):** - **vs. Schizoid PD (Cluster A):** Schizoid patients are indifferent to relationships and prefer solitude (emotionally cold, no desire for intimacy). Avoidant patients desire relationships but fear rejection. - **vs. Social anxiety disorder:** The fear is limited to specific social or performance situations and is less tied to pervasive self-identity, though the two overlap significantly. AvPD is more pervasive, with deeper identity-level inadequacy. - **vs. Dependent PD:** Dependent patients are clingy and seek reassurance and caretaking and fear abandonment. Avoidant patients withdraw from relationships due to fear of rejection. - **vs. Schizotypal PD:** Schizotypal patients show odd beliefs, magical thinking, and eccentric behavior. - **vs. Paranoid PD:** Paranoid patients avoid closeness due to distrust and suspicion of others' malevolent intent, not fear of embarrassment.
**Classic vignette:** A 28-year-old man works night shift stocking shelves to avoid coworkers, has no close friends besides family, declines promotions requiring teamwork, and says he'd love a girlfriend but is sure she'd find him boring and reject him. He reports loneliness and low self-esteem.
**Management:** - First-line: psychotherapy. CBT (exposure to feared social situations, cognitive restructuring of negative core beliefs), schema therapy, psychodynamic therapy, and group therapy/social skills training. A strong therapeutic alliance is important, as patients fear criticism from the therapist as well. - Pharmacotherapy: no drug is approved specifically for AvPD. SSRIs/SNRIs are used for comorbid social anxiety, depression, or generalized anxiety. Benzodiazepines are generally avoided given risk of dependence. Beta-blockers (e.g., propranolol) may help performance-type anxiety.
**Prognosis:** Chronic, but symptoms often attenuate with age and with treatment. Functional impairment (occupational and social) can be significant.
Sources
- DSM-5-TR (American Psychiatric Association, 2022) – Cluster C Personality Disorders
- First Aid for the USMLE Step 1 – Psychiatry: Personality Disorders
- Kaplan & Sadock's Synopsis of Psychiatry, 12th ed.
- UWorld Step 1/Step 2 CK – Psychiatry: Personality Disorders
- Pretest/NMS Psychiatry; Step-Up to Medicine/Psychiatry resources
Reviewed by Medusa editorial — medical student review. Information here is for study reference only and is not medical advice. Spotted an error? Let us know.